New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report
Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawa...
Saved in:
Published in: | Psychopharmacology bulletin Vol. 52; no. 3; pp. 72 - 80 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
MedWorks Media Global
27-06-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawal psychosis, yet all of them were male. In this case report, we present a 41-year-old female patient with bipolar disorder and comorbid substance use disorder who developed new-onset psychosis and relapse of manic symptoms following abrupt discontinuation of Suboxone. Manic and psychotic symptoms remitted after a short-term hospitalization with the treatment of an antipsychotic and a mood stabilizer. In addition to discussing this case presentation and treatment approach, we review existing literature and discuss possible underlying mechanisms to enhance understanding of this clinical phenomenon. |
---|---|
AbstractList | Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare clinical presentation. To our best knowledge, only three reports have summarized the characteristic manifestations of buprenorphine withdrawal psychosis, yet all of them were male. In this case report, we present a 41-year-old female patient with bipolar disorder and comorbid substance use disorder who developed new-onset psychosis and relapse of manic symptoms following abrupt discontinuation of Suboxone. Manic and psychotic symptoms remitted after a short-term hospitalization with the treatment of an antipsychotic and a mood stabilizer. In addition to discussing this case presentation and treatment approach, we review existing literature and discuss possible underlying mechanisms to enhance understanding of this clinical phenomenon. |
Author | Zhang, Alexander D White, Justin B Farrell, Jessica A Lin, Yezhe Kablinger, Anita S Qi, Ansi Trestman, Robert L Sun, Ching-Fang Martin, Rachel K |
Author_xml | – sequence: 1 givenname: Yezhe surname: Lin fullname: Lin, Yezhe organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 2 givenname: Alexander D surname: Zhang fullname: Zhang, Alexander D organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 3 givenname: Ching-Fang surname: Sun fullname: Sun, Ching-Fang organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 4 givenname: Justin B surname: White fullname: White, Justin B organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 5 givenname: Ansi surname: Qi fullname: Qi, Ansi organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 6 givenname: Jessica A surname: Farrell fullname: Farrell, Jessica A organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 7 givenname: Robert L surname: Trestman fullname: Trestman, Robert L organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 8 givenname: Rachel K surname: Martin fullname: Martin, Rachel K organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China – sequence: 9 givenname: Anita S surname: Kablinger fullname: Kablinger, Anita S organization: Lin, MD, Sun, MD, White, MD, Farrell, MD, Trestman, MD, Martin, MD, Kablinger, MD, Department of Psychiatry and Behavioral Science, Carilion Clinic-Virginia Tech Carilion School of Medicine, Roanoke, VA, USA; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Zhang, BA, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Qi, MD, Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35815178$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkGtLwzAUhoNM3EX_guQPFJtrUz8I23QqjG14-VzSLl0jbRLS1Lkf4X-24gX9dOA9PM85vGMwMNaoIzDCNMERplQMwCiOqYhYwukQjNv2JY4RTTk7AUPCBGIoESPwvlL7aG1aFeCmPRSVDbqAj4fGBdu0cGHr2u612cFp7jsX4KxzXhnrXaWNuljJ2r71Z-G1bgtrgjadDNoaqA2UcKEaWSu46SNlAtzrUMGZdraW_hOwfqv8JZzCuWwVfFDO-nAKjktZt-rse07A8-LmaX4XLde39_PpMnJIoBAVlCtZppgnBBGeCpLIkuItJqKkjCQlKQtW5DIvUpowQjDCecoE51JikcdSkAm4-vK6Lm_Utuj_87LOnNeN9IfMSp393xhdZTv7mqWYMIJ4Lzj_K_glf4olH9a2eyI |
ContentType | Journal Article |
Copyright | Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. 2022 |
Copyright_xml | – notice: Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. – notice: Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. 2022 |
DBID | CGR CUY CVF ECM EIF NPM 5PM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2472-2448 |
EndPage | 80 |
ExternalDocumentID | 35815178 |
Genre | Review Case Reports |
GroupedDBID | --- -~X 5RE ABOCM ABPPZ ACNCT AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF E3Z EBS ECM EIF EJD EMOBN F5P MK0 NPM OK1 RPM SJN SV3 TWZ WH7 5PM |
ID | FETCH-LOGICAL-p181t-c46eaf926731369837af42d238f4537f3fc5cbabc947533212b95866aa28b0a83 |
IEDL.DBID | RPM |
ISSN | 0048-5764 |
IngestDate | Tue Sep 17 21:30:14 EDT 2024 Sat Sep 28 08:14:08 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Keywords | buprenorphine two-hit hypothesis psychosis substance-withdrawal mania |
Language | English |
License | Copyright © 1964–2022 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p181t-c46eaf926731369837af42d238f4537f3fc5cbabc947533212b95866aa28b0a83 |
PMID | 35815178 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9235316 pubmed_primary_35815178 |
PublicationCentury | 2000 |
PublicationDate | 20220627 |
PublicationDateYYYYMMDD | 2022-06-27 |
PublicationDate_xml | – month: 6 year: 2022 text: 20220627 day: 27 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Psychopharmacology bulletin |
PublicationTitleAlternate | Psychopharmacol Bull |
PublicationYear | 2022 |
Publisher | MedWorks Media Global |
Publisher_xml | – name: MedWorks Media Global |
SSID | ssj0014965 |
Score | 1.8491858 |
SecondaryResourceType | review_article |
Snippet | Buprenorphine and naloxone (Suboxone) is a combination medication-assisted treatment (MAT) for opioid use disorder. MAT withdrawal-induced psychosis is a rare... |
SourceID | pubmedcentral pubmed |
SourceType | Open Access Repository Index Database |
StartPage | 72 |
SubjectTerms | Adult Antipsychotic Agents - therapeutic use Bipolar Disorder - drug therapy Buprenorphine - adverse effects Buprenorphine, Naloxone Drug Combination - therapeutic use Complicated Case History Female Humans Male Naloxone - adverse effects Psychotic Disorders - drug therapy Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - etiology |
Title | New-Onset Psychotic Symptoms Following Abrupt Buprenorphine/Naloxone Discontinuation in a Female Patient with Bipolar Disorder: A Case Report |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35815178 https://pubmed.ncbi.nlm.nih.gov/PMC9235316 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JTsMwEIYt2hMXxL6jOaCeappmdbh1FRdKpYLErbKdREQii5pU0IfgnRnHTUuvnOMokcfy_08y_oaQe4FZT-BzSb2IBdSWjFOfhT5lJsq5wwInYlUT25k3eWfDkcLkOPVZmKpoX4r4If1MHtL4o6qtzBPZqevEOtPnAZoSXDpup0Ea6A3rFH3960AB0PVvZUbRTKvGO4rx5XRVJ7WNyuxWQP6RlPEhOVh7QejpZx6RvTA9Jq2phkmv2vC6PRtVtKEF0y1menVCfnB_oi9pEZagdzEcBrNVkpdZUsAY45t9oS5BTyyWeQn9paJXZjitiowx4Z_Zd5aGMIwLVa0epxr5DXEKHMZhgroBU81cBfWtFvpxrrJgqHGdj9CDAUogaAt_St7Go9fBE103V6A5inpJpe2GPPJN17O6lutjnsoj2wxQwSPbsbzIiqQjBRfStzGjsVDhhO8w1-XcZMLgzDojzRTf84JAwNH1SM49YXLb6XJ0AIYRhNI1hOLdRZfkXM_2PNcEjXkdkEvi7cRhM0BBr3ev4Fqo4Nfr2F_9-85rsm-qIwyGS03vhjTLxTK8JY0iWN5VC-kXdmjU3A |
link.rule.ids | 230,315,729,782,786,887,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3JTsMwEIYtKAe4sO_bHBAnTNOsDre2UIGAUokicatsJxGRmkUkFfQheGfGcQP0yjmOZGkc___E428IOROY9QQ-l9SLWEBtyTj1WehTZqKcOyxwIlY1sX32-q_s-kZhcpz6LkxVtC9FfJmOk8s0fqtqK_NENus6sebgsYumBJeO21wkS_i9GkadpM8ODxQCXR8sM4p2WrXeUZQvp6V6qf3ozHwN5B9R6a39czrrZHXmIqGtH2-QhTDdJOcDjaGeXsDw91ZVcQHnMPgFVE-3yBfubPQpLcIS9P6Hw-B5muRllhTQw5WRfaCiQVu8T_ISOhPFvcwwIIqp0efj7DNLQ7iOC1XnHqcaFg5xChx6YYKKAwNNawX1lxc6ca7yZ6hBn1fQhi6KJ2jzv01eejfD7i2dtWWgOdqBkkrbDXnkm65ntSzXxwyXR7YZoPZHtmN5kRVJRwoupG9jLmShNgrfYa7LucmEwZm1QxopznOPQMDRL0nOPWFy22lx9A6GEYTSNYQi5UX7ZFdHaZRr9saoDuQ-8ebi9zNA4bLnn2DYKmz2LEwH_37zlCzfDh8fRg93_ftDsmKqixCGS03viDTK90l4TBaLYHJSLcZvl0PqYQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LT9wwEMetspUQl5byaCmvOSBOmM3m6XDbB1ERsEQCpN5WthOrkTYPkaza_RD9zh3Huwt7Lec4kqVx_P9PPP4NIWcCs54k5JIGiiXUlYzTkKUhZTbKuccST7G2ie1jMP7JRtcak7Nq9dUW7UuRXRbT_LLIfrW1lVUuu8s6sW58P0RTgkvH71aJ6m6Qj_jNWvYyUV8cIGgMujlcZhQttW6_o0lfXk_3U1tpzXod5BthiT6_Y0rb5NPCTULfDPlCPqTFDjmPDY56fgFPr7er6gs4h_gVVD3fJX9xh6MPRZ02YPZBHAaP87xqyryGCFdI-RuVDfriZVY1MJhp_mWJgdFsjTGfln_KIoVRVut696ww0HDICuAQpTkqD8SG2gr6by8Mskrn0bAEfl5BH4YoomCSgD3yHF0_DX_QRXsGWqEtaKh0_ZSr0PYDp-f4IWa6XLl2gh5AuZ4TKEdJTwouZOhiTuSgRorQY77Puc2ExZmzTzoFzvMbgYSjb5KcB8Lmrtfj6CEsK0mlbwlNzFMH5KuJ1KQyDI7JMpgHJFiL4WqAxmavP8HQtfjsRai-__ebp2QzHkWTu5vx7SHZsvV9CMundnBEOs3LLD0mG3UyO2nX4z_e-uzh |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New-Onset+Psychotic+Symptoms+Following+Abrupt+Buprenorphine%2FNaloxone+Discontinuation+in+a+Female+Patient+with+Bipolar+Disorder%3A+A+Case+Report&rft.jtitle=Psychopharmacology+bulletin&rft.au=Lin%2C+Yezhe&rft.au=Zhang%2C+Alexander+D&rft.au=Sun%2C+Ching-Fang&rft.au=White%2C+Justin+B&rft.date=2022-06-27&rft.pub=MedWorks+Media+Global&rft.issn=0048-5764&rft.eissn=2472-2448&rft.volume=52&rft.issue=3&rft.spage=72&rft.epage=80&rft_id=info%3Apmid%2F35815178&rft.externalDBID=PMC9235316 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0048-5764&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0048-5764&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0048-5764&client=summon |